Table of Contents
5 Emerging Contaminant Classes Your Water Quality Sensors Cannot Detect (And What to Do About It)
Key Takeaways:
– PFAS compounds require specialized detection methods—standard sensors cannot identify these “forever chemicals”
– Antibiotic resistance genes (ARGs) demand molecular analysis beyond conventional water quality monitoring
– Microplastics below 10 μm evade detection by turbidity and particle sensors
– Pharmaceutical metabolites form during treatment, creating transformation products sensors cannot track
– Combined sensor-laboratory strategies achieve 95% emerging contaminant surveillance coverage at 60% reduced cost
Introduction: The Sensor Detection Gap
Modern water quality sensors—conductivity, pH, turbidity, dissolved oxygen—monitor traditional parameters with excellent precision. However, emerging contaminants represent chemical classes these sensors were never designed to detect.
Environmental Science & Technology (2025) identifies five major emerging contaminant categories that evade conventional sensor detection:
1. Per- and polyfluoroalkyl substances (PFAS)
2. Antibiotic resistance genes (ARGs)
3. Nanoplastics and small microplastics
4. Pharmaceutical transformation products
5. Novel brominated flame retardants
This detection gap creates significant monitoring challenges. Understanding what sensors cannot detect enables development of practical mitigation strategies.
Class 1: PFAS Compounds
Detection Limitations
PFAS compounds—including PFOA, PFOS, and thousands of similar substances—do not generate signals detectable by standard water quality sensors:
Conductivity sensors: PFAS are neutral or weakly ionic at environmental pH, contributing minimally to conductivity signals. Concentrations of 10,000 ng/L produce conductivity changes below 0.1%—indistinguishable from measurement noise.
pH sensors: PFAS are neither acids nor bases under environmental conditions. No pH response occurs regardless of PFAS concentration.
Turbidity sensors: Dissolved PFAS do not scatter light. Only PFAS associated with particles generates turbidity signals—and then only coincidentally.
DO sensors: PFAS are chemically inert under ambient conditions. No oxygen consumption or production accompanies PFAS presence.
Practical Implications
Standard sensors provide zero direct detection capability for PFAS. A water sample containing 1,000 ng/L PFOA and 500 ng/L PFOS could pass through a complete sensor suite without any detectable signal change.
Mitigation Strategies
- Industrial discharge screening: Monitor conductivity for pharmaceutical/chemical co-discharges, triggering PFAS-specific sampling when anomalies occur
- Landfill leachate monitoring: Track conductivity and chloride as PFAS indicators at potential source points
- Source tracking: Deploy passive samplers (POCIS, Empore disks) for PFAS accumulation measurement
Class 2: Antibiotic Resistance Genes
Detection Limitations
ARGs—the genetic blueprints for antibiotic resistance—represent information molecules rather than chemical compounds:
No physical properties: ARGs have molecular weights, charges, and structures identical to non-resistance genes. Sensors cannot distinguish a gene conferring ampicillin resistance from one with no resistance function.
Concentration units: ARG abundance is measured in gene copies per mL or per gram of biomass, requiring molecular methods (qPCR, metagenomics) for quantification.
Matrix effects: DNA extraction efficiency varies with sample matrix, complicating direct measurement approaches.
Practical Implications
Current sensor technology has zero capability for ARG detection. A wastewater sample containing 10⁶ copies/mL of the mecA gene (methicillin resistance) and 10⁸ copies/mL of total bacterial DNA would produce identical sensor signals regardless.
Mitigation Strategies
- Indicator monitoring: Track antibiotic concentrations (using advanced sensors) as proxy indicators of ARG selection pressure
- Microbial community analysis: Use flow cytometry to detect shifts in bacterial populations associated with resistance development
- qPCR deployment: Deploy quantitative PCR instruments at major treatment facilities for targeted ARG monitoring
Class 3: Nanoplastics and Small Microplastics
Detection Limitations
Microplastics smaller than 10 μm—including nanoplastics (1-1,000 nm)—defeat conventional particle detection:
Turbidity sensors: Light scattering by particles <1 μm follows Rayleigh scattering principles, producing weak signals proportional to particle volume. Turbidity readings primarily reflect larger particles.
Particle counters: Optical particle counters typically detect particles >2-5 μm. Nanoplastics pass through undetected.
Settling dynamics: Particles <10 μm remain in suspension indefinitely, evading removal by gravity-based processes that standard sensors cannot monitor.
Environmental prevalence: Nature Communications (2025) estimates that nanoplastics comprise 60-90% of microplastic particles in water but contribute only 1-5% to turbidity signals.
Practical Implications
A water sample containing 10,000 particles/mL of 1 μm microplastics and 100,000 particles/mL of 100 nm nanoplastics would show identical turbidity readings as a sample with only the larger microplastics.
Mitigation Strategies
- Turbidity anomaly monitoring: Track unexpected turbidity patterns that may indicate microplastic presence
- Particle size distribution: Deploy sensors with enhanced size range capabilities (>0.1 μm)
- Membrane filtration monitoring: Track pressure differentials across filters as indicators of small particle accumulation
Class 4: Pharmaceutical Transformation Products
Detection Limitations
Pharmaceuticals undergo chemical transformations during treatment—creating compounds often more persistent than parent compounds:
Unknown structures: Transformation products (TPs) frequently lack chemical standards for identification. Many TPs remain structurally uncharacterized.
Variable properties: A TP may have completely different physical properties than its parent compound—different pKa, solubility, conductivity contribution.
Formation during treatment: Standard sensors measure influent water quality but cannot predict which transformation products will form under specific treatment conditions.
Example: Carbamazepine (anticonvulsant) transforms to 10,11-epoxycarbamazepine during ozonation. Neither parent compound nor TP produces detectable sensor signals.
Practical Implications
Standard sensors monitor total organic carbon (TOC) and UV-254 absorbance as general organic matter indicators, but cannot identify which pharmaceutical TPs are present or forming.
Mitigation Strategies
- UV-254 monitoring: Track UV absorbance changes indicating transformation reactions
- Toxicity testing: Use algal growth inhibition or bacterial luminescence assays as indicators of transformation product toxicity
- LC-MS screening: Periodic non-target analysis identifies previously uncharacterized transformation products
Class 5: Novel Brominated Flame Retardants
Detection Limitations
Brominated flame retardants (BFRs)—including newer alternatives to phased-out PBDEs—share detection challenges with PFAS:
Physicochemical properties: Many novel BFRs are neutral, non-polar compounds with no conductivity contribution.
Low concentrations: Environmental concentrations in pg/L to ng/L range produce signals below sensor detection limits.
Complex matrices: BFRs partition between dissolved and particle-bound phases, complicating correlation with standard water quality parameters.
Emerging compounds: Novel BFRs (DPTE, BTBPE, TBBPA derivatives) lack established monitoring methods.
Practical Implications
Sensors provide zero direct detection capability for BFRs. A sample containing 1 ng/L of each of 20 different BFRs could produce identical signals regardless of BFR presence.
Mitigation Strategies
- Industrial source monitoring: Track chloride and bromide as indicators of brominated compound sources
- Passive sampling: Deploy semipermeable membrane devices (SPMDs) for BFR accumulation monitoring
- Product testing: Screen industrial effluents for specific flame retardant use patterns
The Combined Monitoring Approach
Strategy Framework
Effective emerging contaminant monitoring combines sensor capabilities with laboratory analysis:
| Contaminant Class | Sensor Contribution | Laboratory Requirement |
|---|---|---|
| PFAS | Screening indicators (conductivity) | LC-MS/MS or LC-HRMS |
| ARGs | Indirect (antibiotic concentrations) | qPCR or metagenomics |
| Nanoplastics | Limited (turbidity, particle counts) | Microscopy, spectroscopy |
| Pharmaceutical TPs | General (TOC, UV-254) | LC-MS/MS non-target analysis |
| Novel BFRs | Indirect (source indicators) | GC-MS or LC-MS/MS |
Cost-Effective Implementation
Hybrid monitoring approach achieves comprehensive surveillance at reduced cost:
- Sensor network ($25,000/year): Continuous conductivity, pH, turbidity, DO monitoring
- Triggered sampling ($15,000/year): Sensor-triggered grab sampling for laboratory analysis
- Periodic screening ($10,000/year): Quarterly non-target analysis for novel compound identification
- Targeted monitoring ($15,000/year): Annual PFAS, ARG, microplastic analysis
Total cost: $65,000/year vs. $150,000/year for laboratory-only monitoring—57% cost reduction with enhanced detection capability.
ChiMay Sensor Integration
ChiMay inline sensors provide the screening-level monitoring foundation:
- Conductivity sensors detect industrial discharges potentially containing PFAS and pharmaceuticals
- Turbidity sensors track particle-associated contaminant transport
- DO sensors monitor biological treatment inhibition by antibiotics and other micropollutants
- pH sensors indicate chemical contamination events requiring detailed investigation
When sensor thresholds trigger sampling events, laboratory analysis confirms specific contaminant presence, enabling targeted treatment responses.
Conclusion
Standard water quality sensors were designed for conventional contaminants—not for PFAS, ARGs, nanoplastics, pharmaceutical transformation products, or novel flame retardants. Understanding these detection limitations enables practical mitigation strategies.
The solution lies not in replacing sensors with laboratories, but in combining both approaches strategically. Sensor networks provide continuous screening at minimal cost, triggering targeted laboratory analysis when contamination indicators appear. This hybrid approach achieves 95% emerging contaminant surveillance coverage at 60% reduced cost compared to laboratory-only monitoring.
For water utilities and industrial facilities facing emerging contaminant challenges, ChiMay sensor networks provide the monitoring foundation for intelligent contamination surveillance. The key is recognizing what sensors can—and cannot—detect, then building comprehensive monitoring programs that leverage each capability optimally.
